• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病大流行期间全身性炎症性疾病管理中的实际问题

Practical Issues in Managing Systemic Inflammatory Disorders During the COVID-19 Pandemic.

作者信息

Dimitroulas Theodoros, Bertsias George

机构信息

4 Department of Internal Medicine, Hipokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Rheumatology and Clinical Immunology, University of Crete Medical School and University Hospital of Iraklio, Iraklio, Greece.

出版信息

Mediterr J Rheumatol. 2020 Sep 8;31(Suppl 2):253-256. doi: 10.31138/mjr.31.3.253. eCollection 2020 Sep.

DOI:10.31138/mjr.31.3.253
PMID:33196001
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7656127/
Abstract

The global coronavirus disease 2019 (COVID-19) situation threatens not only the health of populations, but also the coherence and function of health care systems. Patients with systemic inflammatory disorders feel the overwhelming strain of COVID-19, since their disease, administered treatments, and associated comorbidities may all contribute to increased vulnerability to infection. At the same time, monitoring the activity status of rheumatic diseases and adjusting the treatments where appropriate, are important for preventing flares and other complications, which could pose additional health risks. Considering the urgent need to maintain physical distancing and self-quarantine as much as possible, we herein discuss the challenges and possible solutions pertaining to the assessment and monitoring of patients with systemic inflammatory diseases. We also discuss issues related to the prescription and supply of anti-rheumatic drugs, as well as opportunities provided by the use of technological and wireless tools. From an optimistic viewpoint, the end of this pandemic may leave us with an important legacy in utilising and implementing e-health solutions that may both improve the clinical care standards for patients with systemic inflammatory diseases and also reduce the burden placed on healthcare systems.

摘要

全球2019冠状病毒病(COVID-19)疫情不仅威胁着民众的健康,也对医疗保健系统的连贯性和功能构成挑战。患有全身性炎症性疾病的患者感受到了COVID-19带来的巨大压力,因为他们的疾病、正在接受的治疗以及相关的合并症都可能导致感染易感性增加。与此同时,监测风湿性疾病的活动状态并在适当的时候调整治疗,对于预防病情复发和其他并发症很重要,这些并发症可能会带来额外的健康风险。鉴于迫切需要尽可能保持社交距离和自我隔离,我们在此讨论全身性炎症性疾病患者评估和监测方面的挑战及可能的解决方案。我们还将讨论抗风湿药物的处方和供应相关问题,以及使用技术和无线工具带来的机遇。从乐观的角度来看,这场大流行的结束可能会给我们留下一份重要遗产,即利用和实施电子健康解决方案,这既可以提高全身性炎症性疾病患者的临床护理标准,又可以减轻医疗保健系统的负担。

相似文献

1
Practical Issues in Managing Systemic Inflammatory Disorders During the COVID-19 Pandemic.2019冠状病毒病大流行期间全身性炎症性疾病管理中的实际问题
Mediterr J Rheumatol. 2020 Sep 8;31(Suppl 2):253-256. doi: 10.31138/mjr.31.3.253. eCollection 2020 Sep.
2
Tuberculosis结核病
3
[Comparison of health-related quality of life between patients with rheumatic diseases and a control group].[风湿性疾病患者与对照组之间健康相关生活质量的比较]
Medicina (Kaunas). 2005;41(7):561-5.
4
Case Series of Chronic Inflammatory Rheumatic Disease Patients Infected by Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病(COVID-19)感染慢性炎症性风湿性疾病患者的病例系列
Case Rep Rheumatol. 2020 Nov 12;2020:8860492. doi: 10.1155/2020/8860492. eCollection 2020.
5
Suspected inflammatory rheumatic diseases in patients presenting with skin rashes.疑似以皮疹为表现的炎症性风湿性疾病。
Best Pract Res Clin Rheumatol. 2019 Aug;33(4):101440. doi: 10.1016/j.berh.2019.101440. Epub 2019 Oct 1.
6
COVID-19 and Telepsychiatry: Development of Evidence-Based Guidance for Clinicians.新型冠状病毒肺炎与远程精神病学:为临床医生制定循证指南
JMIR Ment Health. 2020 Aug 28;7(8):e21108. doi: 10.2196/21108.
7
Evaluation of Mental Health Factors among People with Systemic Lupus Erythematosus during the SARS-CoV-2 Pandemic.新冠疫情期间系统性红斑狼疮患者心理健康因素评估
J Clin Med. 2020 Sep 5;9(9):2872. doi: 10.3390/jcm9092872.
8
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases.新冠疫情对系统性风湿疾病患者的影响。
Lancet Rheumatol. 2021 Oct;3(10):e675-e676. doi: 10.1016/S2665-9913(21)00243-5. Epub 2021 Jul 22.
9
Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic.在2019冠状病毒病大流行期间管理接受利妥昔单抗治疗的风湿性疾病患者。
Lancet Rheumatol. 2021 Jun;3(6):e395-e396. doi: 10.1016/S2665-9913(21)00077-1. Epub 2021 Mar 25.
10
Incident systemic rheumatic disease following COVID-19.新型冠状病毒肺炎(COVID-19)后发生的系统性风湿性疾病
Lancet Rheumatol. 2021 Jun;3(6):e402-e404. doi: 10.1016/S2665-9913(21)00106-5. Epub 2021 Apr 6.

引用本文的文献

1
Technologies and main functionalities of the telemonitoring application reCOVeryaID.远程监测应用程序reCOVeryaID的技术与主要功能。
Front Big Data. 2024 Jul 22;7:1360092. doi: 10.3389/fdata.2024.1360092. eCollection 2024.
2
An intelligent telemonitoring application for coronavirus patients: reCOVeryaID.一款用于新冠病毒患者的智能远程监测应用程序:reCOVeryaID。
Front Big Data. 2023 Sep 18;6:1205766. doi: 10.3389/fdata.2023.1205766. eCollection 2023.
3
Preventive Behaviors and Mental Health-Related Symptoms Among Immunocompromised Adults During the COVID-19 Pandemic: An Analysis of the COVID Impact Survey.免疫功能低下的成年人在 COVID-19 大流行期间的预防行为和与心理健康相关的症状:COVID 影响调查分析。
AIDS Res Hum Retroviruses. 2021 Apr;37(4):304-313. doi: 10.1089/AID.2020.0302.

本文引用的文献

1
When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?当大流行发生时,没有时间可以浪费:我们的应对新冠肺炎感染患者的手段中应该有羟氯喹吗?
Mediterr J Rheumatol. 2020 Mar 31;31(1):94-97. doi: 10.31138/mjr.31.1.94. eCollection 2020 Mar.
2
Recommendations Regarding COVID19 Infection in Rheumatic Patients in Greece.关于希腊风湿性疾病患者新冠病毒感染的建议
Mediterr J Rheumatol. 2020 Mar 31;31(1):6-7. doi: 10.31138/mjr.31.1.6. eCollection 2020 Mar.
3
Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology.羟氯喹用于治疗新型冠状病毒肺炎所引发的热潮给风湿病学带来了挑战。
Lancet Rheumatol. 2020 May;2(5):e257. doi: 10.1016/S2665-9913(20)30089-8. Epub 2020 Apr 1.
4
Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.2019年冠状病毒病:对系统性红斑狼疮患者护理与管理的启示
Eur J Rheumatol. 2020 Aug;7(Suppl 2):S117-S120. doi: 10.5152/eurjrheum.2020.20055. Epub 2020 Apr 8.
5
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.抗风湿药物的抗病毒作用:COVID-19 带来的启示。
J Autoimmun. 2020 Jul;111:102468. doi: 10.1016/j.jaut.2020.102468. Epub 2020 Apr 17.
6
Off-label use of tocilizumab in patients with SARS-CoV-2 infection.托珠单抗在新型冠状病毒肺炎患者中的超说明书用药
J Med Virol. 2020 Oct;92(10):1787-1788. doi: 10.1002/jmv.25897. Epub 2020 Jun 29.
7
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.预测 SARS-CoV-2 的传播动力学,直至大流行后期。
Science. 2020 May 22;368(6493):860-868. doi: 10.1126/science.abb5793. Epub 2020 Apr 14.
8
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.COVID-19 全球风湿病联盟:大流行期间的数据收集。
Nat Rev Rheumatol. 2020 Jun;16(6):293-294. doi: 10.1038/s41584-020-0418-0.
9
COVID-19, rheumatic diseases and immunosuppressive drugs: an appeal for medication adherence.2019冠状病毒病、风湿性疾病与免疫抑制药物:呼吁坚持用药
Rheumatol Int. 2020 May;40(5):827-828. doi: 10.1007/s00296-020-04566-9. Epub 2020 Mar 30.
10
Flares in systemic lupus erythematosus: diagnosis, risk factors and preventive strategies.系统性红斑狼疮的病情活动:诊断、危险因素及预防策略
Mediterr J Rheumatol. 2017 Mar 28;28(1):4-12. doi: 10.31138/mjr.28.1.4. eCollection 2017 Mar.